Cite
MLA Citation
D. Lorente et al.. “2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC).” European journal of cancer, vol. 51, n.d., pp. S504–. http://access.bl.uk/ark:/81055/vdc_100030628240.0x00005c